Journal of Endocrinological Investigation

, Volume 22, Issue 4, pp 241–249 | Cite as

Diagnosis of Cushing’s syndrome: Re-evaluation of midnight plasma cortisol vs urinary free cortisol and low-dose dexamethasone suppression test in a large patient group

  • R. Görges
  • G. Knappe
  • H. Gerl
  • M. Ventz
  • F. Stahl
Original Article


We studied plasma cortisol levels at 00:00 h and 08:00 h in 103 patients with Cushing’s syndrome and 144 patients in whom this diagnosis had been excluded. These patients were hospitalized in our department from 1975 to 1996. Additionally, we measured these parameters in 20 healthy volunteers and in 5 patients with nonendocrine disease. Corresponding data of urinary free cortisol and low-dose dexamethasone suppression testing were included in the evaluation. Values (mean±SD) from patients with Cushing’s syndrome: 510±232 nmol/l (range 165–1488) for plasma cortisol 00:00 h, 574±242 nmol/l (range 236–1612) for plasma cortisol 08:00 h, 991±885 nmol/24 h (range 154–4866) for urinary free cortisol and 479±304 nmol/l (range 34–1,393) for plasma cortisol after 1.5 mg dexamethasone. Values from the patients excluded from Cushing’s syndrome: 99±76 nmol/l (range 5–371) for plasma cortisol 00:00 h, 393±136 nmol/l (range 119–812) for plasma cortisol 08:00 h, 126±84 nmol/24 h (range 30–485) for urinary free cortisol, and 64±82 nmol/l (range 5–395) for plasma cortisol after 1.5 mg dexamethasone. Values of the healthy volunteers respectively patients with non-endocrine disease: 59±30 nmol/l (range 25–130) respectively 127±80 nmol/l (range 62–265) for plasma cortisol 00:00 h and 388±144 nmol/l (range 157–651) respectively 498±113 nmol/l (range 302–581) for plasma cortisol 08:00 h. None of the Cushing patients exhibited a 00:00 h plasma cortisol below 140 nmol/l and only one had a urinary free cortisol below 200 nmol/24 h, whereas 4 were complete dexamethasone suppressors. The diagnostic value of these parameters was examined based on various cutoffs. We recommend determination of midnight plasma cortisol as an efficient and simple additional procedure for the diagnosis of Cushing’s syndrome. The sensitivity and specificity of this procedure is similar to urinary free cortisol and slightly above the low-dose dexamethasone suppression testing in our hospitalized patients.


Cushing’s syndrome laboratory diagnostics midnight plasma cortisol urinary free cortisol low-dose dexamethasone suppression test 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kaye T.B., Crapo L. The Cushing syndrome: An update of diagnostic tests. Ann. Intern. Med. 172: 434, 1990.CrossRefGoogle Scholar
  2. 2.
    Caduff F., Staub J.J., Nordmann A., Radü E.W., Landolt H. Diagnostik des Cushing-Syndroms. Schweiz. Med. Wochenschr. 121: 10, 1991.PubMedGoogle Scholar
  3. 3.
    Trainer P.J., Grossman, A. The diagnosis and differential diagnosis of Cushing’s syndrome. Clin. Endocrinol. (Oxf.) 34: 317, 1991.CrossRefGoogle Scholar
  4. 4.
    Shapiro M.S., Shenkman L. Variable hormonogenesis in Cushing’s syndrome. Q. J. Med. 79: 351, 1991.PubMedGoogle Scholar
  5. 5.
    Tsigos C., Chrousos G.P. Differential diagnosis and management of Cushing’s syndrome. Annu. Rev. Med. 47: 443, 1996.PubMedCrossRefGoogle Scholar
  6. 6.
    Friedman T.C., Yanovski J.A. Morning plasma free cortisol: inability to distinguish patients with mild Cushing syndrome from patients with pseudo Cushing states. J. Endocrinol. Invest. 18: 696, 1995.PubMedGoogle Scholar
  7. 7.
    Hellman L., Weitzman E.D., Roffwarg H. Cortisol is secreted episodically in Cushing’s syndrome. J. Clin. Endocrinol. Metab. 30: 686, 1970.PubMedCrossRefGoogle Scholar
  8. 8.
    Sederberg-Olsen P., Binder C., Kehlet H., Neville A.M., Nilsen L.M. Episodic variation in plasma corticosteroids in subjects with Cushing’s syndrome of differing etiology. J. Clin. Endocrinol. Metab. 36: 906, 1973.PubMedCrossRefGoogle Scholar
  9. 9.
    Boyar R.M., Witkin M., Carruth A., Ramsey J. Circadian cortisol secretory rhythms in Cushing’s disease. J. Clin. Endocrinol. Metab. 48: 760, 1979.PubMedCrossRefGoogle Scholar
  10. 10.
    Vagnucci A.H., Wang T.P., Pratt V., Li C.C. Classification of plasma cortisol patterns in normal subjects and in Cushing’s syndrome. IEEE Trans. Biomed. Eng. 38: 113, 1991.PubMedCrossRefGoogle Scholar
  11. 11.
    Zadik Z., de Lacerda L., Kowarski A.A. Evaluation of the 6-hour integrated concentration of cortisol as a diagnostic procedure for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 54: 1072, 1982.PubMedCrossRefGoogle Scholar
  12. 12.
    Loriaux D.L. Cushing’s syndrome. In: Becker K.L. (Ed.), Principles and practise of endocrinology and metabolism. J.B. Lippincott, Philadelphia, 1990, p. 595.Google Scholar
  13. 13.
    Crapo L. Cushing’s syndrome: A review of diagnostic tests. Metabolism 28: 955, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Kley H.K. Physiologie, Pathophysiologie, Klinik, Diagnostik und internistische Therapie-Nebennierenrinde. In: Kummerle F., Lenner V. (Eds.), Erkrankungen der Nebennieren. Thieme, Stuttgart, 1985, p. 41.Google Scholar
  15. 15.
    Baxter J.D., Tyrrell J.B. The adrenal cortex. In: Fehlig P., Baxter J.D., Broadus A.E., Frohman L.A. (Eds.), Endocrinology and metabolism, ed. 2. McGraw-Hill, New York, 1987, p. 511.Google Scholar
  16. 16.
    Meikle A.W. Secretion and metabolism of the cortico-steroids and adrenal function and testing. In: DeGroot L.J. (Ed.), Endocrinology. W.B. Saunders, Philadelphia, 1989, p. 1610.Google Scholar
  17. 17.
    Orth D.N., Kovacs W.J., DeBold C.R. The adrenal cortex. In: Wilson J.D., Foster D.W. (Eds.), Williams textbook of endocrinology. W.B. Saunders, Philadelphia, 1992, p. 489.Google Scholar
  18. 18.
    Newell-Price J., Trainer P., Perry L., Wass J., Grossman A., Besser M. A single midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin. Endocrinol. (Oxf.) 43: 545, 1995.CrossRefGoogle Scholar
  19. 19.
    Hellman L., Nakada F., Curti J. Cortisol is secreted episodically in normal man. J. Clin. Endocrinol. Metab. 30: 411, 1970.PubMedCrossRefGoogle Scholar
  20. 20.
    Vetter H., Strass R., Bayer J.M., Beckerhoff R., Armbruster H., Vetter V. Short-term fluctuations in plasma cortisol in Cushing’s syndrome. Clin. Endocrinol. (Oxf.) 6: 1, 1968.CrossRefGoogle Scholar
  21. 21.
    Stahl F., Hubl W., Schnorr D., Dörner G. Evaluation of a competitive binding assay for cortisol using horse transcortin. Endokrinologie 72: 214, 1978.PubMedGoogle Scholar
  22. 22.
    Gerl H., Knappe G., Rohde W., Stahl F., Wolff H., Martin H. Cushing-Syndrom bei CRF-produzierendem mediastinalen Karzinoid. Dtsch. Med. Wochenschr. 115: 332, 1990.PubMedCrossRefGoogle Scholar
  23. 23.
    Gerl H., Rückert J.C., Rohde W., Knappe G., Ventz M. Rare combination of ectopic Cushing’s syndrome and Zollinger-Ellison syndrome with endocrine tumor of the pancreas. Exp. Clin. Endocrinol. Diabetes 103: A 54 (Abstract), 1995.Google Scholar
  24. 24.
    Nelson D.H. Cushing’s syndrome. In: DeGroot L.J. (Ed.), Endocrinology. W.B. Saunders, Philadelphia, 1989, p. 1660.Google Scholar
  25. 25.
    Benker G., Schulte H.M., Günther R.W., Reinwein D. Diagnostische Strategien beim Cushing-Syndrom. In: Allolio B., Schulte H.M. (Eds.), Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkankungen. Schattauer, Stuttgart-New York, 1990, p. 74.Google Scholar
  26. 26.
    Kley H.K. Endokrines System-Nebennierenrinde. In: Kümmerle H.P. (Ed.), Methoden der klinischen Pharmakologie. Urban & Schwarzenberg, München, 1978, p. 539.Google Scholar
  27. 27.
    Müller J. Sinnvolle und sinnlose Steroidbestimmungen: Zweckmäßige Labordiagnostik der Nebennieren-Funktion. Schweiz. Med. Wochenschr. 121: 482, 1991.PubMedGoogle Scholar
  28. 28.
    Olsen N.J., Fang V.S., DeGroot L.J. Cushing’s syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm. Metabolism 27: 695, 1978.PubMedCrossRefGoogle Scholar
  29. 29.
    Glass A.R., Zavadil A.P., Halberg F., Cornelissen G., Schaaf M. Circadian rhythm of serum cortisol in Cushing’s disease. J. Clin. Endocrinol. Metab. 59: 161, 1984.PubMedCrossRefGoogle Scholar
  30. 30.
    Aron D.C., Tyrell J.B., Fitzgerald P.C., Findling J.W., Forsham P.H. Cushing’s syndrome: problems in diagnosis. Medicine (Baltimore) 60: 25, 1981.CrossRefGoogle Scholar
  31. 31.
    Loriaux D.L., Cutler G.B. Diseases of the adrenal glands. In: Kohler P.O., Jordan R.M. (Eds.), Clinical endocrinology. John Wiley & Sons, New York, 1986, p. 167.Google Scholar
  32. 32.
    Vidal-Trecan G., Laudat M.H,. Thomopoulos P., Luton J.P., Bricaire H. Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing’s syndrome. Acta Endocrinol. (Copenh.) 103: 110, 1983.Google Scholar
  33. 33.
    Snow K., Jiang N.S., Kao P.C., Scheithauer B.W. Biochemical evaluation of adrenal dysfunction: the laboratory perspective. Mayo Clin. Proc. 67: 1055, 1992.PubMedCrossRefGoogle Scholar
  34. 34.
    Contreras L.N., Hane S., Tyrrell J.B. Urinary cortisol in the assessment of pituitaryadrenal function: utility of 24-hour and spot determinations. J. Clin. Endocrinol. Metab. 62: 965, 1986.PubMedCrossRefGoogle Scholar
  35. 35.
    Mengden T., Hubmann P., Müller J., Greminger P., Vetter W. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing’s syndrome. Clin. Investig. 70: 545, 1992.PubMedGoogle Scholar
  36. 36.
    Cronin C., Igoe D., Duffy M.J., Cunningham S.K., McKenna T.J. The overnight dexamethasone test is a worthwhile screening procedure. Clin. Endocrinol. (Oxf.) 33: 27, 1990.CrossRefGoogle Scholar
  37. 37.
    Fok A.C.K., Tan K.T., Jacob E., Sum C.F. Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing’s syndrome. Steroids 56: 549, 1991.PubMedCrossRefGoogle Scholar
  38. 38.
    Blethen S.L., Chasalow F.I. Overnight dexamethasone suppression test: normal responses and diagnosis of Cushing’s syndrome. Steroids 54: 185, 1989.PubMedCrossRefGoogle Scholar
  39. 39.
    Brown R.D., Van Loon G.R., Orth D.N., Liddle G.W. Cushing’s disease with periodic hormonogenesis: one explanation for a paradoxial response to dexamethasone. J. Clin. Endocrinol. Metab. 36: 445, 1973.PubMedCrossRefGoogle Scholar
  40. 40.
    Balspratsch M., Hanker J.P., Hellhammer D.H., Ludecke D.K., Schlegel W., Schneider H.P.G. Intermittent Cushing’s disease in hirsute women. Horm. Metab. Res. 28: 105, 1996.CrossRefGoogle Scholar
  41. 41.
    Connolly C.K., Gore M.B.R., Stanley N., Wills M.R. Single-dose dexamethasone suppression in normal subjects and hospital patients. B.M.J. 2: 665, 1968.CrossRefGoogle Scholar
  42. 42.
    Papanicolaou D.A., Yanovski J.A., Cutler G.B., Chrousos G.P., Nieman L.K. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J. Clin. Endocrinol. Metab.J. Clin. Endocrinol. 83: 1163, 1998.Google Scholar
  43. 43.
    Meeran K., Hattersley A., Mould G., Bloom S.R. Venepuncture causes rapid rise in plasma ACTH. Br. J. Clin. Pract. 47: 246, 1993.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1999

Authors and Affiliations

  • R. Görges
    • 1
    • 3
  • G. Knappe
    • 1
  • H. Gerl
    • 1
  • M. Ventz
    • 1
  • F. Stahl
    • 2
  1. 1.Department of Internal Medicine IV (Endocrine Unit)University Hospital “Charité”, Humboldt-Universität BerlinGermany
  2. 2.Institute of Experimental EndocrinologyUniversity Hospital “Charité”, Humboldt-Universität BerlinGermany
  3. 3.Department of Nuclear MedicineKlinikum der Universität GH EssenGermany

Personalised recommendations